Search results for "Enzimi"

showing 10 items of 286 documents

Silver(I), Copper(I) and Copper(II) Complex of the New N,Se-Chelate Ligand 2-Phenylselenomethyl-1H-benzimidazole: Electrochemistry and Structure

2009

Abstract. 2-Phenylselenomethyl-1H-benzimidazole (psbi) can form complexes in 2:1 ratio with coinage metal ions. Crystal structure analysis revealed a flattened metal coordination for [AgI(psbi)2](BF4) (1), approaching a distorted planar arrangement with weak Ag-Se bonds (d > 2.9 A) and confirmed as energy minimum by DFT calculations. The typical Jahn-Teller system [CuII(psbi)2Cl2] (2) exhibits a planar CuN2Cl2 core with weak Se---Cu---Se axial ligation (3.2944(8) A Cu--Se distance). The oxygen-sensitive compound [CuI(psbi)2](BF4) (3) exhibits electrochemically reversible oxidation in contrast to the silver(I) analogue 1.

BenzimidazoleLigandMetal ions in aqueous solutionInorganic chemistrychemistry.chemical_elementCrystal structureElectrochemistryCopperInorganic ChemistryMetalchemistry.chemical_compoundCrystallographychemistryvisual_artvisual_art.visual_art_mediumChelationZeitschrift für anorganische und allgemeine Chemie
researchProduct

Highly Stable and Efficient Light-Emitting Electrochemical Cells Based on Cationic Iridium Complexes Bearing Arylazole Ancillary Ligands.

2017

A series of bis-cyclometalated iridium(III) complexes of general formula [Ir(ppy)2(N∧N)][PF6] (ppy− = 2-phenylpyridinate; N∧N = 2-(1H-imidazol-2-yl)pyridine (1), 2-(2-pyridyl)benzimidazole (2), 1-methyl-2-pyridin-2-yl- 1H-benzimidazole (3), 2-(4′-thiazolyl)benzimidazole (4), 1- methyl-2-(4′-thiazolyl)benzimidazole (5)) is reported, and their use as electroluminescent materials in light-emitting electrochemical cell (LEC) devices is investigated. [2][PF6] and [3][PF6] are orange emitters with intense unstructured emission around 590 nm in acetonitrile solution. [1][PF6], [4][PF6], and [5][PF6] are green weak emitters with structured emission bands peaking around 500 nm. The different photoph…

BenzimidazoleLigandchemistry.chemical_element02 engineering and technologyQuímica analíticaElectroluminescence010402 general chemistry021001 nanoscience & nanotechnologyPhotochemistry01 natural sciences0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundCrystallographychemistryPyridineIridiumChemistry AnalyticPhysical and Theoretical ChemistryTriplet state0210 nano-technologyAcetonitrileHOMO/LUMOInorganic chemistry
researchProduct

Heterocyclic photorearrangements. Photochemical behaviour of some 3,5-disubstituted 1,2,4-oxadiazoles in methanol at 254 nm

1988

Photochemical behaviour of some 3,5-disubstituted 1,2,4-oxadiazoles in methanol at 254 nm has been investigated. Ring photoisomerization to the 1,3,4-oxadiazole heterocycle or formation of open chain compounds involving the nucleophilic solvent was shown to depend on the nature and the position of the substituent. Photoinduced ring closure into the benzimidazole system, involving a 3-N-phenylamino side chain sequence and a photolytic intermediate of the oxadiazole heterocycle, is also reported.

Benzimidazolechemistry.chemical_compoundNucleophilePhotoisomerizationchemistryBicyclic moleculeOrganic ChemistrySide chainSubstituentOxadiazoleRing (chemistry)PhotochemistryJournal of Heterocyclic Chemistry
researchProduct

ChemInform Abstract: Heterocyclic Photorearrangements. Photochemical Behaviour of Some 3,5-Disubstituted 1,2,4-Oxadiazoles in Methanol at 254 nm.

1989

Photochemical behaviour of some 3,5-disubstituted 1,2,4-oxadiazoles in methanol at 254 nm has been investigated. Ring photoisomerization to the 1,3,4-oxadiazole heterocycle or formation of open chain compounds involving the nucleophilic solvent was shown to depend on the nature and the position of the substituent. Photoinduced ring closure into the benzimidazole system, involving a 3-N-phenylamino side chain sequence and a photolytic intermediate of the oxadiazole heterocycle, is also reported.

Benzimidazolechemistry.chemical_compoundPhotoisomerizationNucleophileChemistrySide chainSubstituentOxadiazoleGeneral MedicineMethanolRing (chemistry)PhotochemistryChemInform
researchProduct

Antiarrhythmika. I. 2,4-dialkylpyrimido[1,2-a]benzimidazole

1981

Aus der Umsetzung von 2-Aminobenzimidazol (1) mit β-Diketonen (2a-d) gehen die 2,4-Dialkylpyrimido[1,2-a]benzimidazole (3a-d) hervor.

Benzimidazolechemistry.chemical_compoundchemistryOrganic ChemistryMedicinal chemistryJournal of Heterocyclic Chemistry
researchProduct

Synthese und narkotische Wirkung von Pyrimido[1,2-a]benzimidazol-2,4-dionen Synthesis and Anesthetic Activity of Pyrimido[1,2-a]benzimidazole-2,4-dio…

1982

Eine betrachtliche Zahl zentral dampfender Verbindungen weist als gemeinsames Strukturelement die Carbonamidgruppierung in offenkettiger oder cyclischer Form auf. Unsere jungsten Untersuchungen uber antibakteriell1 und herbizid2 wirksame Pyrimido[1,2-a]benzimidazole legten nun nahe, in die Entwicklung dieser Strukturklasse die Carbonamidgruppierung einzubeziehen.

Benzimidazolechemistry.chemical_compoundchemistryStereochemistryDrug DiscoveryAnestheticmedicinePharmaceutical Sciencemedicine.drugArchiv der Pharmazie
researchProduct

Crystal structure of 5-(5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazolin-6-yl)-2-methoxyphenol

2015

In the molecule of the title compound, C21H17N3O2, the 5,6-dihydrobenzimidazo[1,2-c]quinazoline moiety is disordered over two orientations about a pseudo-mirror plane, with a refined occupancy ratio of 0.863 (2):0.137 (2). The dihedral angles formed by the benzimidazole ring system and the benzene ring of the quinazoline group are 14.28 (5) and 4.7 (3)° for the major and minor disorder components, respectively. An intramolecular O—H...O hydrogen bond is present. In the crystal, molecules are linked by O—H...N hydrogen bonds, forming chains running parallel to [10-1].

Benzimidazolecrystal structurecyclizationCrystallographyHydrogen bondGeneral ChemistryCrystal structureDihedral angleCondensed Matter PhysicsRing (chemistry)BioinformaticsMedicinal chemistryData Reportschemistry.chemical_compoundchemistryQD901-999QuinazolineMoietyGeneral Materials Scienceimidazole derivativeBenzeneActa Crystallographica Section E: Crystallographic Communications
researchProduct

Multiple, alternative cleavage patterns precede uniform larval morphology during normal development of Dreissena polymorpha (Mollusca, Lamellibranchi…

1995

In this study we reinvestigate the early development of the freshwater mussel Dreissena polymorpha, previously studied by Meisenheimer (1901). The data include video time-lapse recordings of living embryos and bisbenzimide stains of fixed embryos as well as morphometry on fixed, serially-sectioned embryos. We present the cell lineage and cell cycle durations up to the first indication of symmetrization within this embryo. We show that early cell cycles last approximately 1h. A dramatic extension of cell cycle duration and a concomitant asynchrony among the various cell lines was observed starting at the fifth cleavage. Short cell cycles, like those of early blastomeres, were a constant prop…

BisbenzimideEmbryoBlastomereAnatomyCell cycleBiologyCleavage (embryo)Embryonic stem cellCell biologychemistry.chemical_compoundSinistral and dextralchemistryGeneticsDevelopmental biologyDevelopmental BiologyRoux's Archives of Developmental Biology
researchProduct

Retrograde transport of sodium selenite and intracellular injection of micro-ruby: a combined method to describe the morphology of zinc-rich neurones.

2003

Abstract Zinc is found in synaptic vesicles in a large number of glutamatergic systems. Its involvement in neurotransmission and neurological disorders has been suggested. There are methods for tracing these circuits, but they do not fill the dendritic tree. In this study, extracellular selenite injections in vivo were combined with intracellular injection of fluorochromes in fixed tissue to reveal the morphology of these zinc-rich neurones. Intraperitoneal and intracerebral injections of sodium selenite alone or intracerebral injections of selenite combined with bisbenzimide were made in the visual cortex of the rat in order to locate the somata of zinc-rich neurones. After 24 h of retrogr…

BisbenzimideMaleSilver StainingBiotinCell CountNeurotransmissionBiologySynaptic vesicleRats Inbred WKYchemistry.chemical_compoundSodium SeleniteBiocytinNeural PathwaysExtracellularAnimalsRats WistarVisual CortexNeuronsLucifer yellowMicroscopy ConfocalRhodaminesGeneral NeuroscienceDrug Administration RoutesLysineDextransSomatosensory CortexIontophoresisIsoquinolinesRatsNeuroanatomyZincnervous systemchemistryBiochemistryAxoplasmic transportBiophysicsInjections JetExtracellular SpaceIntracellularInjections IntraperitonealJournal of neuroscience methods
researchProduct

AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.

2008

Several enzymatic sources of reactive oxygen species (ROS) were described as potential reasons of eNOS uncoupling in diabetes mellitus. In the present study, we investigated the effects of AT1-receptor blockade with chronic telmisartan (25 mg/kg/day, 6.5 weeks) therapy on expression of the BH4-synthesizing enzyme GTP-cyclohydrolase I (GCH-I), eNOS uncoupling, and endothelial dysfunction in streptozotocin (STZ, 60 mg/kg iv, 7 weeks)-induced diabetes mellitus (type I). Telmisartan therapy did not modify blood glucose and body weight. Aortas from diabetic animals had vascular dysfunction as revealed by isometric tension studies (acetylcholine and nitroglycerin potency). Vascular and cardiac RO…

Blood GlucoseMalemedicine.medical_specialtyNitric Oxide Synthase Type IIImedicine.disease_causeBiochemistryBenzoatesReceptor Angiotensin Type 1chemistry.chemical_compoundEnosPhysiology (medical)Internal medicinemedicineDiabetes MellitusAnimalsTelmisartanEndothelial dysfunctionRats WistarXanthine oxidaseGTP CyclohydrolaseNADPH oxidasebiologySuperoxideBody WeightNADPH Oxidasesmedicine.diseaseStreptozotocinbiology.organism_classificationMitochondriaRatsUp-RegulationEnzyme ActivationOxidative StressEndocrinologychemistrybiology.proteinBenzimidazolesTelmisartanAngiotensin II Type 1 Receptor BlockersOxidative stressmedicine.drugFree radical biologymedicine
researchProduct